The video highlights footage from the April 9, 2015 visit of investigative journalists David Daleiden — director of the Center for Medical Progress (CMP) — and CMP employee Sandra Merritt to Planned Parenthood Gulf Coast’s (PPGC) abortion facility in Houston.
“We had two levels of invoicing for them. We had it worded as ‘per consent,’” explains PPGC Director of Research Melissa Farrell. In the video, Farrell states “per consent” is the phrase used in PPGC budgeting in place of “per specimen” for fetal tissue.
Farrell discusses that while a woman may consent to supply her aborted baby’s tissue, the specimen itself may not be useable for experimentation.
“There’s probably some situations where somebody would consent and then just not, we didn’t get a sample, or she changed her mind, or something happened to the specimen,” she says, adding, “Now obviously, we don’t want to end up paying for material that we can’t use,” and suggests that there be a line item fee or “something else that represents the specimens.”
“I just don’t want it to turn into a situation that is not financially beneficial for you,” says Merritt.
“Yeah, yeah. And we’ll, I’ll take you up on that. I’ll take you up on that. I’ll take you up on that,” Farrell repeats, laughing. “We definitely want to do that, because that’s what staff and management need to see.”
PPGC CEO Melaney Linton also appears in the video advising that Farrell will “work on all of that with you” when it comes to “remuneration” and “compensation” for fetal tissue.